FIELD: pharmaceutics.
SUBSTANCE: group of inventions relates to the preparation of an alpha-2A adrenergic receptor agonist, which can be used as a sedative or analgesic. A method for the preparation of 2-(5-methoxy isochroman-1-yl)-4,5-dihydro-1H-imidazole hydrosulfate, formula (Ia), is presented. In another embodiment, a new compound of formula (V) and a method for obtaining it are provided. In the third embodiment, the use of the compound of formula (V) as an intermediate for the preparation of hydrosulfate 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazole, formula (Ia), is presented.
EFFECT: group of inventions provides the preparation of 2-(5-methoxy isochroman-1-yl)-4,5-dihydro-1H-imidazole hydrosulfate, formula (Ia), using a compound of formula (V) with high yield and purity.
10 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 1-(4,5-DIHYDROIMIDAZOLE)-ISOCHROMANE OR 1-(4,5-DIHYDRO)-ISOTHIOCHROMANE, WHICH ARE USEFUL AS AGONISTS OF ALPHA2 ADRENORECEPTORS | 2013 |
|
RU2642065C2 |
BIPHENYL DERIVATIVES AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2109736C1 |
DERIVATIVES OF 7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-3-ENE, USEFUL FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2645678C2 |
HETEROARYL COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2007 |
|
RU2474582C2 |
CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2695219C2 |
XIa FACTOR INHIBITORS | 2016 |
|
RU2712268C2 |
CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
TRICYCLIC DICARBONYL DERIVATIVES AND DRUG BASED ON SAID | 1995 |
|
RU2145606C1 |
METHOD OF PRODUCING 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL) PHENYL] AMINO} -CARBONYL) AMINO]-3-FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, SALTS AND MONOHYDRATE THEREOF | 2011 |
|
RU2581585C2 |
IMIDAZOLINE DERIVATIVES HAVING CB-ANTAGONIST ACTIVITY | 2005 |
|
RU2357958C2 |
Authors
Dates
2023-03-09—Published
2018-11-30—Filed